Show
Sort by
-
Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but functional tolerance in cancer models
-
Heterocellular 3D scaffolds as biomimetic to recapitulate the tumor microenvironment of peritoneal metastases in vitro and in vivo
-
- Journal Article
- A1
- open access
Improved synthesis and comparative analysis of the tool properties of new and existing D-ring modified (S)-blebbistatin analogs
-
- Journal Article
- A1
- open access
Insights into the myosin II inhibitory potency of A-ring-modified (S)-blebbistatin analogs
-
- Journal Article
- A1
- open access
Discovery of (S)-3′-hydroxyblebbistatin and (S)-3′-aminoblebbistatin : polar myosin II inhibitors with superior research tool properties
-
Discovery of anti-invasive tools and leads for the study and treatment of metastatic cancer : two case studies
-
Discovery and development of new anti-invasive agents, an unmet clinical need
-
Discovery of novel nonmuscle myosin II inhibitors as chemical tools and antimetastatic therapeutics leads
-
Discovery of novel nonmuscle myosin II inhibitors as antimetastatic therapeutics leads and chemical tools
-
4-Fluoro-3',4',5'-trimethoxychalcone as a new anti-invasive agent: from discovery to initial validation in an in vivo metastasis model